Ashish Mandelia insider trades
Open-market stock purchases and sales by Ashish Mandelia, VP, Chief Accounting Officer at Mersana Therapeutics, Inc, from SEC Form 4 filings since Jan 15, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $85.5K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $6.8K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $163K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $139K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $27K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $21K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $286K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $408K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $56.4K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $124K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $109K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $179K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $87.4K |
Companies traded
- MRSN Mersana Therapeutics, Inc: 1 buy, 12 sales, last Jan 6, 2026